FDA Inspection 1326890 — Alejandro Mendivil Navarro
The FDA completed an inspection of Alejandro Mendivil Navarro on May 22, 2026 in Barcelona. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 22, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Barcelona (Spain)
Additional Details
Clinical Investigator (CI)